Western blot (immunoblot) analysis of Candida albicans germ tube extracts has demonstrated the probable presence of 13-1,2-linked oligomannosides acting as epitopes distributed over a 14-to 18-kDa antigen unreactive to concanavalin A. These conclusions about the existence of these non-mannan-associated oligomannoside species were reinforced in the present study by the demonstration of reactivity of factor serum 5 (Iatron Laboratories) with the same antigen. A monoclonal antibody which reacted in an enzyme immunoassay with 13-1,2-linked oligomannosides converted into neoglycolipids and in Western blotting with the 14-to 18-kDa antigen from yeast and germ tubes, through metaperiodate-sensitive epitopes, was used for further characterization of the molecule. Reducing agents and strong protease digestion, which have deleterious effects on C. albicans proteins and mannoproteins, affected neither the antigenicity nor the relative molecular weight of the molecule. Western blots performed after migration of protease-treated extracts in polyacrylamide gels without sodium dodecyl sulfate (SDS) showed that the 14-to 18-kDa antigen could be negatively charged, whereas metabolic radiolabeling demonstrated that these charges could originate, at least in part, from the presence of phosphorus within the molecule. Chloroform-methanol-water extraction of protease-resistant material led to
By using monoclonal antibodies (MAbs) reactive with Candida albicans mannan, we recently found a 14-to 18-kDa C. albicans antigen (47) that is unreactive with concanavalin A (ConA), a lectin currently used to characterize yeast mannoproteins (15, 42) through its ability to react with at-D-mannopyranosyl residues (22) . Recognition of the 14-to 18-kDa antigen was restricted to MAbs that were able to react with neoglycolipids contructed from mannan acidlabile oligomannosides (47) . These oligomannosides correspond to homopolymers of mannopyranosyl units bound through (-1,2-linkages (11, 45) , whose expression in Candida mannan has been extensively studied by Suzuki's group (23-28, [38] [39] [40] [41] [43] [44] [45] but whose association with other Candida molecules is unknown.
From a physiopathological point of view, Western blotting (immunoblotting) analysis of the recognition of C. albicans antigens by human sera (18) has shown that control sera reacted to the same extent with both ConA-reactive highmolecular-weight mannoproteins and the 14-to 18-kDa antigen, a pattern that could account for the well-known presence of antibodies reacting with C. albicans polysaccharides in sera from healthy individuals (17, 18, 21, 33) . However, despite increased levels of antibodies against ConA-reactive high-molecular-weight mannoproteins, some * Corresponding author. sera from patients with candidosis failed to react with the 14-to 18-kDa antigen or even lost this reactivity during infection (18) .
The present work was therefore devoted to elucidation of the nature of the 14-to 18-kDa antigen, which has none of the properties so far described for any C. albicans molecule. The first part of this analysis concerned the presence of (-1,2-linked oligomannosides acting as epitopes distributed over the 14-to 18-kDa antigen polysaccharide moiety. The presence of such oligomannosides has already been suggested by the use of both MAbs (47) and patient immunoglobulin G3 (IgG3) (34) in a joint analysis by Western blotting and enzyme-linked immunosorbent assay (ELISA) against mannan-derived oligomannosides converted to neoglycolipids. For this purpose, we used polyclonal factor serum 5, which has recently been shown to be specific for (3-1,2-linked oligomannosides by conventional methods of inhibition of antibody binding to mannan by oligomannosides rather than with neoantigens (38) .
The second part of this study concerned the analysis of the nonglycan moiety of the 14-to 18-kDa molecule. The 14-to 18-kDa antigen was characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and antigenicity with a MAb (3) selected for its strong reactivity for two other MAbs (47) . The use of different methods of cellular extraction, enzymatic digestion, and radiolabeling led to the conclusion that the 14-to 18-kDa antigen was not a mannoprotein but a phospholipomannan.
MATERIALS AND METHODS
Strain and culture conditions. C. albicans VW.32 (serotype A) was used throughout this study. The strain was maintained routinely on Sabouraud agar. Yeast cells were grown for 24 h at 28°C on the same medium. For germ tube formation, yeast cells were washed in phosphate-buffered saline (PBS) and then allowed to germinate at a concentration of 5 x 106 cells per ml in RPMI medium at 37°C for 4 h. Under these conditions, at least 95% of the yeasts were converted to germ tubes. Polyclonal antibodies and MAbs. Monospecific rabbit antisera for antigenic factors 1, 4, 5, 6, and 13b (Candida Check; batch S 158) were purchased from Iatron Laboratories (Tokyo, Japan). Except for factor serum 1, which is an unabsorbed antiserum against C. albicans whole cells, all factor sera were absorbed by cells from various Candida species in order to obtain monospecific antisera for yeast identification purposes (12) .
MAbs generated against Candida mannoproteins were selected for their ability to react with polysaccharidic determinants. These were MAb AF1, a mouse IgM (5), kindly provided by A. Cassone (Istituto Superiore de Sanita, Rome, Italy), and MAb EB-CAl (13), a rat IgM, kindly provided by D. Stynen (Sanofi/Diagnostic Pasteur, Genk, Belgium). Their reactivity against both C albicans mannan-released oligomannosides and C. albicans mannoproteins has been established previously (47) . However, for the present study, we mainly used another MAb, designated DF9-3. This MAb is a mouse IgM generated against Candida tropicalis acid proteinase (37) by the procedures recently described for two other MAbs generated during the same set of experiments (3) . MAb DF9-3 was purified from mouse ascitic fluids by gel filtration. Dilutions were made from an original concentration of 5.4 mg/ml. ELISA of C. albicans mannan-released oligomannosides converted to neoglycolipids. This ELISA method has been described previously in recent reports (9, 10) . Briefly, phosphopeptidomannan was extracted by the method of Koucourek and Ballou with modifications (10) . Oligomannoside families were obtained by sequential depolymerization of phosphopeptidomannan by acid hydrolysis (10, 11) 1-elimination (17) , and acetolysis (9) . To allow coating of oligomannosides on micro-ELISA plates, they were converted into neoglycolipids by covalent coupling to 4-hexadecylaniline (10) . Plates were coated with 0.1 ,ug of neoglycolipids, and MAbs were used at dilutions from 1:100 to 1:400. The corresponding peroxidase-conjugated antibodies (either anti-mouse IgM or anti-rat IgM; Zymed, Biosoft, Paris, France) were used at a 1:500 dilution.
Standard procedures for cellular extraction and Western blotting. Yeast cells and germ tube extracts were obtained by a method of alkali extraction under reducing conditions, (AERC), which allows extraction of cytoplasmic and cell wall proteins and glycoproteins and has led to previous identification of the 14-to 18-kDa antigen (18, 34, 47) . Briefly, cells were incubated first at 4°C in 1.85 N NaOH-5% 2-mercaptoethanol. After addition of 5% trichloroacetic acid and a second incubation at 4°C, the cell pellet was washed, without stirring, with 1 M Tris and then extracted at 100°C for 5 min in an SDS sample buffer. For purification and further characterization of the 14-to 18-kDa antigen, we used French press (Fp) extracts of germ tubes. The cells were broken by two consecutive runs in a French pressure cell (Aminco, Silver Spring, Md.) at 20,000 lb/in2. After centrifugation at 2,500 x g for 15 min, the supematant was dialyzed and dried in a Speed Vac concentrator (Savant Instuments, Farmingdale, N.Y.).
PAGE was performed for 18 h at a constant current of 4 mA on linear 5 to 15% polyacrylamide gradient gel slabs (14 cm wide by 14 cm; 0.75 mm thick). Standard procedures involved a sample buffer with SDS and 2-mercaptoethanol. However, some gels were run without either SDS or 2-mercaptoethanol. Gels were stained with Coomassie blue or with silver (32) when greater sensitivity was needed. After electrophoresis of samples labeled with [3H]mannose or [3H]palmitic acid, fixed gels were soaked in En3Hance (Beckman, Gagny, France) and exposed to X-OMat film (Eastman Kodak, Rochester, N.Y.) at -80°C for fluorography.
Electrotransfer was performed with a semidry blotter apparatus (Biometra, Gottingen, Germany) at 1 mA/cm2 for 1 h.
Treatment of blots. For identification of mannoproteins, strips were blocked with 5% bovine serum albumin in buffer A (50 mM Tris-HCl, 150 mM NaCl [pH 7.5]) and incubated with 1 ,g of ConA-horseradish peroxidase (ConA-HRP) in buffer A plus 0.05% Tween 20 for 1 h at 37°C. Strips were then developed in buffer A containing 0.05% diaminobenzidine and 0.1% H202.
For immunodetections with MAbs DF9-3 and AF1, strips were blocked with 5% nonfat dry milk in buffer A for 45 min at 37°C and then incubated for 1 h at 37°C successively with MAbs diluted 1:800 and with the same peroxidase conjugate as used for ELISA, diluted 1:600. Visualization was performed as above.
To check MAb specificity against polysaccharidic determinants, blots were treated for 20 min at room temperature with 0.1% H104 in 0.1 M acetate buffer, pH 5.5, prior to immunodetection (50) . Controls consisted of strips incubated in the acetate buffer alone (34) .
32PO4H2Na-labeled components on blots were revealed by exposing the nitrocellulose to an X-Omat film for 36 h at -80°C. The strips were then cut in the nitrocellulose sheet and treated for immunodetection, as described above, to assess surimposition of radiolabeling with antigenic recogni- Glycolipid extraction and control of purification. Proteinase K-resistant material was subjected to a first extraction with chloroform-methanol (2:1). The residual pellet was then extracted with chloroform-methanol-water (CMW) (10:10:3) (46). The extracts were then dried on a Buchi apparatus.
RESULTS
Reactivity of MAbs against C. albicans mannan-derived oligomannosides established following construction of neoglycolipids. When tested in an ELISA against C. albicans mannan-derived oligomannosides converted into neoglycolipids ( Fig. 1) , all the MAbs reacted very faintly with alkali-labile oligomannosides. The reactivity pattern displayed by MAb EB-CAl showed preferential recognition of acetolysis-released oligomannosides, which contrasted with the low reactivity against acid-labile oligomannosides. Both MAbs DF9-3 and AF1 exhibited strong reactivity against acid-labile oligomannosides and low reactivity against acetolysis-released oligomannosides. Better discrimination between homopolymers of 13-1,2-linked oligomannosides, known to be constituents of acid-labile oligomannosides (11) , and other families of mannan-derived oligomannosides was observed for MAb DF9-3.
Recognition of 14-to 18-kDa antigen polysaccharidic moiety by antibodies reacting with "-1,2-linked oligomannosides in Western blotting and after degradation with periodate. Factor sera 1, 4, 5, 6, and 13b from Candida Check displayed reactivity against an AERC extract from C. albicans germ tubes which involved either high molecular weight mannoproteins, the 14-to 18-kDa antigen, or both (Fig. 2, lanes 1 to  5) . Reactivity with the 14-to 18-kDa antigen occurred only with factor sera 1, 4, and 5, the last being the least reactive with other molecular species. MAbs AF1 and DF9-3 presented a reactivity pattern that was more specific for the 14 (Fig. 3, lane 4) . Similarly, ConA-HRP staining of the blot from the Fp extract gave results comparable to those of the AERC procedure (47), revealing high-molecular-weight polydispersed components and a large number of well-resolved bands, none of which was superimposed on that of the 14-to 18-kDa antigen (Fig. 3, lane 3) .
Treatment of the blots with periodic acid prior to immunodetection resulted in a complete loss of MAb DF9-3 reactivity (Fig. 3, lanes 1 and 2) , confirming the saccharidic nature of the corresponding epitope.
Potential contribution of protein moiety to the 14-to 18-kDa antigen examined by degradation with proteases. As similar results for the 14 Western blotting performed after SDS-PAGE of the Fp extract under nonreducing conditions (absence of 2-mercaptoethanol) exhibited an unchanged pattern for the 14-to 18-kDa antigen as revealed by MAb DF9-3, demonstrating that this molecule is not a subunit released from a highermolecular-weight mannoprotein(s).
Treatment of the Fp extract with proteinase K resulted in the disappearance of proteins on SDS-polyacrylamide gels: Coomassie blue staining was restricted to a broad area of peptides smaller than 14 kDa (Fig. 4A, lanes 1 and 2) . Moreover, when the corresponding Western blot was revealed by using ConA-HRP (Fig. 4A, lane 3) , a strong decrease in reactivity compared with that of untreated material (Fig. 3, lane 3) was observed. Immunodetection with MAb DF9-3 showed that proteinase K treatment affected neither the immunological reactivity nor the size of the 14-to 18-kDa antigen (Fig. 4A, lane 4) . Subsequent incubations with pronase did not modify these results (data not shown). Nature of the component leading to the presence of negative charges on the 14-to 18-kDa antigen examined by radiolabeling. When Western blotting of proteinase K-resistant material was carried out after PAGE in the absence of SDS, a single dispersed component reacting with MAb DF9-3 was revealed (Fig. 4B) . This observation led to the conclusion that the molecule was negatively charged under the electrophoresis conditions in use.
After metabolic labelling with 32PO4H2Na, Western blots of SDS-PAGE-determined proteinase K-resistant material showed that the fraction revealed by MAb DF9-3 was
[32P]phosphate labeled (Fig. 4A, lanes 5 and 6) 5A, lanes 1 and 2), complete disappearance of proteins and glycoproteins as assessed, respectively, by silver stain of the gel and ConA-HRP staining of the blot (Fig. SB, lanes 1 and  2) . Despite the apparent lack of material in SDS-PAGE and Western blotting, the presence of the 14-to 18-kDa antigen, revealed through its reactivity with MAb DF9-3, remained unaffected ( Fig. 5A and B, lanes 3) by the glycolipid extraction procedure.
Metabolic labeling performed with mannose (Fig. 6A ) or palmitic acid (Fig. 6B ) demonstrated, in untreated whole-cell extracts, the association of both radiolabels with highmolecular-weight polydispersed material and the 14-to 18-kDa antigen (Fig. 6A and B, lanes 1) . When autoradiography was performed on CMW-purified material, comigration of incorporated mannose and palmitic acid demonstrated the glycolipidic nature of the 14-to 18-kDa antigen.
DISCUSSION
Our interest in the 14-to 18-kDa antigen arose from the demonstration of the probable presence at this level of 0-1,2-linked oligomannosides acting as epitopes (47) . The existence of ,3-1,2-linked mannopyranosyl residues in C. albicans was first reported by Shibata et al. in a structural analysis of the cell wall mannan (40) . This initial description was followed by a considerable number of structural studies by the same group, relating to the presence of these residues within different Candida species and strains grown under various conditions (23-28, 38-41, 43-45 hydrolysis conditions were used and more strains of the same species were explored, some initial statements (44) were brought into question (24, 43) . At the moment, it appears that within phospho-D-mannan protein complexes, ,B-1,2-linked oligomannosides exist at two different levels. The first one corresponds to the nonreducing end of a-1,2-linked oligomannosides belonging to the acid-stable domain of the phosphopeptidomannan, where mannopentaose and mannohexaose represent a chemotype which corresponds to C. albicans serotype A (28) (antigenic factor 6), shared by Candida glabrata (25) and, theoretically, by C. tropicalis (12). 13-1,2-linked oligomannosides consisting of homopolymers with a polymerization degree of up to 7 (40) or even 12 (11) are also present in the acid-labile domain of the phosphopeptidomannan extracted from the cell wall of C albicans of both serotypes A and B (27, 40) . These oligomannosides show a decrease in their degree of polymerization during the yeast-mycelium transition (39, 41) and were found to be absent from the cell wall when C albicans was grown at pH 2 (23) .
Recently, it has been demonstrated that the chemotype represented by Candida acid-labile oligomannosides corresponds to antigenic factor 5, a serotype shared by C. albicans, Candida stellatoidea, C tropicalis, and C glabrata (38) . When such acid-labile oligomannosides prepared from a C. albicans serotype A strain were converted into neoglycolipids to study their immunoreactivity in ELISA, a correlation was observed between the reactivity of anti-C. albicans mannan MAbs towards this neoantigen and their reactivity against a 14-to 18-kDa antigen extracted from whole C. albicans cells (47) . The fact that MAb reactivity against the 14-to 18-kDa antigen was restricted to MAbs reacting with acid-labile oligomannosides indicates that such residues could act as MAb epitopes distributed over the molecule. This conclusion was reinforced by using sera from patients infected with C. albicans; the ability of these sera to react with the 14-to 18-kDa antigen through IgG3 was observed only for sera which could, at a given time during the disease, react with acid-labile oligomannosides through this special subclass of immunoglobulin (34) .
In the present study, we used another type of immunological probe, a rabbit polyclonal IgG, factor serum 5 (12) . The specificity of such factor sera adsorbed with whole cells can be established only at the surface level. However, it has recently been demonstrated by another group, using a method of inhibition of antibody binding to mannan by mannan-derived oligomannosides, that factor 5 corresponds to homopolymers of 1-1,2-linked mannopyranosyl units (38) .
In the present work, the fact that factor serum 5 reacted with the 14-to 18-kDa antigen reinforces the already established strong probability that non-mannan-associated 3-1,2-linked oligomannosides could exist as epitopes distributed over the 14-to 18-kDa antigen. To proceed further in the analysis of this molecule, we used MAbs reacting with 1-1,2-linked oligomannosides as tools for characterization through the purification steps. In comparison with the panel of MAbs already tested (47) , some of which have been used in the present study, MAb DF9-3, generated by one of us against C. tropicalis (3, 37), a Candida species that has antigen 5 (12), appeared to be the best candidate; it bound very faintly to acetolysis-released oligomannosides but reacted strongly, even at low concentrations, with both acid-labile oligomannosides and the 14-to 18-kDa antigen, confirming our previous observations (47) . Furthermore, oxidation with periodate has shown that, although the 14-to 18-kDa antigen did not bind to ConA, its recognition by MAb DF9-3 occurred through metaperiodate-sensitive epitopes. Such sensitivity is observed for oligosaccharides whose linkage retains free OH vicinal groups (7) as do 13,1-2-linked mannopyranosyl residues.
The Western blotting procedure used for the initial description of the 14-to 18-kDa antigen involved alkali extraction of germ tubes under reducing conditions (47) . In the present study, application of the same procedure to yeast cells has demonstrated that the antigen was extant in these growth forms, while subsequent radiolabelings have evidenced its de novo synthesis during germ tube formation. From a technical point of view, the material from the SDS extraction step of the AERC procedure, used for direct electrophoretic analysis, was not suitable for further biochemical studies. (15, 19) and the presence of bands reactive with patient sera (21, 33 The absence of detectable proteins within the 14-to 18-kDa antigen raised the question of how the polysaccharidic moiety, detected through its antigenic activity, could bind to polystyrene plates (data not shown) or to nitrocellulose, since polysaccharides generally cannot bind to these matrices. Although very few studies have involved C. albicans glycolipids (14) , these components have been described for a wide variety of microorganisms, including bacteria (6, 20, 35, 36) , yeasts (8) , and protozoa of the genera Plasmodium (2) , Leishmania (16, 48) , Trypanosoma (31), and Toxoplasma (46) . Considering that some of these microbial glycolipids behave like low-molecular-weight polydispersed components in SDS-PAGE (8, 20, 30) , a strong similarity could be observed with the 14-to 18-kDa antigen. We therefore decided to use glycolipid extraction of the semipurified 14-to 18-kDa antigen obtained after protease digestion of an Fp extract. This consisted in extraction with chloroform-methanol to remove neutral lipids, phospholipids, and less polar glycolipids and treatment of the residual pellet with CMW to extract more polar glycolipids (47) . CMW allowed efficient extraction of the 14-to 18-kDa antigen, and as proved by SDS-PAGE and Western blotting, this approach provided an excellent gauge of purification. Final demonstration of the nature of the 14-to 18-kDa antigen was obtained by metabolic labeling with mannose and palmitic acid. In whole-cell extracts, as well as in purified CMW extracts, both of these components were shown to have been incorporated at the 14-to 18-kDa level during cell growth. This presence of mannose associated with nonreactivity to ConA was a complementary argument for the presence of 1-man linkages at the 14-to 18-kDa antigen level, as suspected from the immunological tests. The presence of palmitic acid established that the 14-to 18-kDa glycoconjugate antigen was a lipopolysaccharide.
Together, the results obtained in this study led us to define the C. albicans 14-to 18-kDa antigen as a PLM. At the moment, it appears that this molecule, expressed by both C. albicans blastoconidia and germ tubes, is present in C. stellatoidea and C. tropicalis but not in other Candida species (3a) . However, complete elucidation of the structure, biosynthesis, and expression of this Candida PLM will require numerous investigations. More generally, the demonstration of the existence of this PLM, expressed by an opportunistic fungus, coincides with the publication of an extensive literature about glycolipids from a wide variety of pathogenic microorganisms; these have been demonstrated as key molecules in both cell biology (6, 8, 20, 31, 35, 46, 48) and physiopathological processes (16, 20, 29, 35, 48) . The potential role of the C. albicans PLM in both Candida cell biology and pathogenicity therefore deserves to be explored in relation to the numerous questions raised by its observation. On a fundamental point of view, it must be determined whether this original phosphorylated glycolipid, containing non-mannan-associated 3-1,2 oligomannosides, is a precursor for the biosynthesis of these oligomannoside branches (43) or is a special type of yeast glycosylphosphatidylinositol anchor molecule (8) , or whether it has other functions within Candida cells. From a physiopathological point of view, it must be determined whether the C. albicans PLM, like other structurally related microbial glycolipids, i.e., mycobacterial lipoarabinomannan (1) , Leishmania lipophosphoglycan (48) , and Plasmodium glycosylphosphatidylinositol (2) , is an inducer of cytokines, namely, tumor necrosis factor.
